Elena K. Beloglazkina

Moscow, MOW 119991, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

New redox-active Cu complexes with tridentate chelating ligands based on 2-thioimidazol-4-ones as potential antiproliferative agents.

New redox-active Cu complexes with tridentate chelating ligands based on 2-thioimidazol-4-ones as potential antiproliferative agents.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: May 22, 2026

Aggregation polymorphism of photoactivatable Pt(IV) prodrugs as a strategy for the design of theranostic nanomaterials.

Aggregation polymorphism of photoactivatable Pt(IV) prodrugs as a strategy for the design of theranostic nanomaterials.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: May 18, 2026

A Review of Approaches to the Synthesis of DCL-Based Prostate-Specific Membrane Antigen Ligands.

A Review of Approaches to the Synthesis of DCL-Based Prostate-Specific Membrane Antigen Ligands.

Journal: International journal of molecular sciences

Published: April 08, 2026

Structure-property relationships of benzyl-substituted urea-based ligands with Phe-Phe linker targeting prostate-specific membrane antigen labeled with gallium-68.

Structure-property relationships of benzyl-substituted urea-based ligands with Phe-Phe linker targeting prostate-specific membrane antigen labeled with gallium-68.

Journal: Bioorganic chemistry

Published: March 16, 2026

Dispiroindolinone-Glutarimide Conjugates: Synthesis and Evaluation as Potential Hetero-PROTACs for p53 Reactivation.

Dispiroindolinone-Glutarimide Conjugates: Synthesis and Evaluation as Potential Hetero-PROTACs for p53 Reactivation.

Journal: Molecules (Basel, Switzerland)

Published: March 13, 2026

Bimodal Fluorescent Conjugate Based on Prostate-Specific Membrane Antigen Ligands with the Chelating Agent DOTA and SulfoCy5 Dye: Synthesis, Radiolabeling, and Biological Activity.

Bimodal Fluorescent Conjugate Based on Prostate-Specific Membrane Antigen Ligands with the Chelating Agent DOTA and SulfoCy5 Dye: Synthesis, Radiolabeling, and Biological Activity.

Journal: International journal of molecular sciences

Published: March 12, 2026

Heavy-Atom-Free Dual-Action Dual PACT/PDT action Pt(IV) Prodrug With BODIPY Dimer in Axial Position.

Heavy-Atom-Free Dual-Action Dual PACT/PDT action Pt(IV) Prodrug With BODIPY Dimer in Axial Position.

Journal: ChemMedChem

Published: February 18, 2026

Evolution of PSMA-GRPr heterobivalent radiolabeled conjugates for the diagnosis and therapy of prostate cancer.

Evolution of PSMA-GRPr heterobivalent radiolabeled conjugates for the diagnosis and therapy of prostate cancer.

Journal: European journal of medicinal chemistry

Published: February 18, 2026

The Complex of Copper (II) and Zoledronic Acid: Relevance to Oxidative Death of Leukemia Cells in the Bone Marrow.

The Complex of Copper (II) and Zoledronic Acid: Relevance to Oxidative Death of Leukemia Cells in the Bone Marrow.

Journal: International journal of molecular sciences

Published: January 11, 2026

Nanocarrier-based delivery of Pt(IV) compounds for chemoimmunotherapy and theranostics: Advances, challenges, and prospects.

Nanocarrier-based delivery of Pt(IV) compounds for chemoimmunotherapy and theranostics: Advances, challenges, and prospects.

Journal: Acta pharmaceutica Sinica. B

Published: November 28, 2025

A mild and atom-efficient four-component cascade strategy for the construction of biologically relevant 4-hydroxyquinolin-2(1H)-one derivatives.

A mild and atom-efficient four-component cascade strategy for the construction of biologically relevant 4-hydroxyquinolin-2(1H)-one derivatives.

Journal: Beilstein journal of organic chemistry

Published: November 02, 2025

A series of conjugates based on prostate-specific membrane antigen ligands with the chelating agent DOTA: synthesis, radiolabeling, and biological activity.

A series of conjugates based on prostate-specific membrane antigen ligands with the chelating agent DOTA: synthesis, radiolabeling, and biological activity.

Journal: European journal of medicinal chemistry

Published: October 02, 2025

Showing 1-12 of 90

Last Updated: 09/26/2026